EnteroMedics Announces vBloc Therapy to be Presented by Keynote Speaker at Major International Obesity Conference

ST. PAUL, Minn., June 21, 2017 -- (Healthcare Sales & Marketing Network) -- EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that Scott Shikora, M... Devices EnteroMedics, vBloc , Neurometabolic Therapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news